Galeano-Valle Fransico, Díaz-Crespo F J, Melero-Martín R, Apaza-Chávez J E, Del-Toro-Cervera J, Demelo-Rodríguez P
Deparment of Internal Medicine, Hospital General Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
CEN Case Rep. 2019 Aug;8(3):166-172. doi: 10.1007/s13730-019-00385-5. Epub 2019 Feb 2.
Crystal-storing histiocytosis (CSH) is a rare disorder characterized by the accumulation of nonneoplastic histiocytes containing intracytoplasmic crystallized immunoglobulins. In most cases, there is an associated underlying lymphoplasmacytic neoplasm expressing Ig kappa light chain. About 131 cases of CSH have been identified. There is a localized and a generalized form of CSH and it can involve several sites including bone marrow, lungs, lymph nodes, liver, spleen, gastrointestinal tract, and kidney. Generalized CSH is less frequent and involves multiple organs and tends to have a worst prognosis than localized CSH. Around 20 cases of renal involvement in CSH have been reported so far. Paraprotein-induced crystalline nephropathy can be divided into two categories based on whether the crystals in the kidney are intracellular (including light chain proximal tubulopathy with crystals and CSH) or extracellular (including the crystalline variant of myeloma cast nephropathy and crystalglobulin-induced nephropathy). The former tends to present with slowly worsening kidney dysfunction and generally has a good prognosis, whereas the latter usually presents with rapidly progressive renal failure and is associated with poor renal outcome. We present a case of generalized CSH associated with extracellular crystalline nephropathy with a fulminant and fatal clinical course. Kappa light-chain crystals were found exclusively extracellularly within the tubular lumen, not within the tubular epithelial cells nor the histiocytes, and the massive presence of those precipitates led to the acute renal failure. Consequently, we review the renal involvement in CSH in the literature and discuss the unique mechanism of renal injury in this case.
晶体储存组织细胞增多症(CSH)是一种罕见的疾病,其特征是含有胞质内结晶免疫球蛋白的非肿瘤性组织细胞积聚。在大多数情况下,存在一种相关的潜在淋巴浆细胞性肿瘤,表达Igκ轻链。已确诊约131例CSH病例。CSH有局限性和全身性两种形式,可累及多个部位,包括骨髓、肺、淋巴结、肝脏、脾脏、胃肠道和肾脏。全身性CSH较少见,累及多个器官,预后往往比局限性CSH更差。迄今为止,已报道约20例CSH累及肾脏的病例。副蛋白诱导的结晶性肾病可根据肾脏中的晶体是细胞内(包括有晶体的轻链近端肾小管病和CSH)还是细胞外(包括骨髓瘤管型肾病的结晶变体和晶体球蛋白诱导的肾病)分为两类。前者往往表现为肾功能逐渐恶化,总体预后良好,而后者通常表现为快速进展性肾衰竭,且肾脏预后较差。我们报告一例全身性CSH合并细胞外结晶性肾病,临床过程凶险且致命。κ轻链晶体仅在肾小管腔内细胞外发现,不在肾小管上皮细胞或组织细胞内,这些沉淀物的大量存在导致了急性肾衰竭。因此,我们回顾了文献中CSH累及肾脏的情况,并讨论了该病例中独特的肾损伤机制。